Related Experiment Video
Updated: Feb 10, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Echocardiographic parameters to identify sickle cell patients with cardio-pathology
Simbo Chiadika1, Mary Lim-Fung1, Fiorella Llanos-Chea2
1Division of Cardiology, Department of Internal Medicine, The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.
Insights
Sickle cell disease (SCD) significantly impacts heart function, with many patients showing abnormal cardiac parameters. Echocardiography can identify these abnormalities, aiding in risk assessment for better patient outcomes.
Area of Science:
- Cardiology
- Hematology
- Medical Imaging
Background:
- Sickle cell disease (SCD) is a genetic blood disorder causing chronic hemolytic anemia.
- Anemia in SCD leads to vasculopathies, including pulmonary hypertension and cardiac dysfunction.
- These cardiac abnormalities increase morbidity and mortality in SCD patients.
Purpose of the Study:
- To assess the prevalence of echocardiographic parameters in patients with SCD.
- To identify specific cardiac abnormalities associated with SCD.
- To evaluate echocardiographic findings as potential indicators of cardiopulmonary risk in SCD.
Main Methods:
- Retrospective analysis of 91 SCD patients (53% male, median age 30).
- Measurement of laboratory and echocardiographic parameters, including left ventricular (LV) dimensions, ejection fraction (LVEF), myocardial performance index (MPI), mass index (MI), and left atrial volume index (LAVI).
- Assessment of right heart dimensions, tricuspid regurgitation velocity (TRV), and tricuspid annular plane systolic excursion (TAPSE).
Main Results:
- A high prevalence of left heart abnormalities was observed: 78% had abnormal LV MPI, 38% decreased LVEF, 24% increased LVMI, and 47% increased LAVI.
- Right heart abnormalities were also common: 59% had increased pulmonary systolic pressure (PASP), 38% increased TRV, and 39% abnormal TAPSE.
- Increased LVMI and LAVI were significantly associated with hemoglobin levels ≤8 g/dL.
Conclusions:
- SCD is associated with a high prevalence of left and right heart abnormalities, including abnormal LV MPI, LVMI, diastolic function, LAVI, and PASP.
- Echocardiographic parameters such as LV MPI and TAPSE are frequently abnormal in SCD patients.
- These echocardiographic findings represent accessible prognostic tools for identifying cardiopulmonary risk in the SCD population.
Background:
Sickle cell disease (SCD) affects millions of people and causes chronic hemolytic anemia leading to vasculopathies such as pulmonary hypertension and abnormalities in cardiac function that increase complications and mortality. It is therefore crucial to identify cardiac abnormalities in SCD. We aimed to assess the prevalence of echocardiographic parameters in SCD to help identify cardiopulmonary risk.
Methods:
Ninety-one patients (53% male), median age of 30, body surface area (BSA) of 1.79 m2 , hemoglobin of 8.8 g/dL, and creatinine of 0.7 mg/dL identified. We retrospectively measured laboratory and echocardiographic parameters in patients with SCD : left ventricular (LV) dimensions, LV ejection fraction (LVEF), LV Myocardial Performance Index (MPI), LV Mass Index (MI), Left Atrial Volume Index (LAVI), Tricuspid Regurgitation Velocity (TRV), tricuspid annular plane systolic excursion (TAPSE), right heart dimensions.
Results:
Prevalence of left heart abnormalities was 32%: increased LV end-diastolic diameter (EDD), 78%: LV MPI, 21%: diastolic dysfunction, 38%: decreased LVEF, 24%: increased LVMI, and 47%: increased LAVI. Right heart abnormalities were 39%: TAPSE, 38%: increased TRV, and 59%: increased pulmonary systolic pressure (PASP). Multivariate logistic regression analysis was significant for increased LVMI and LAVI in those with hemoglobin ≤8 g/dL (odds ratio (OR) 7.4, 95% confidence interval (CI) 2.23-24.6, P = .001) and (OR 3.32, 95% CI 1.18-9.33, P = .023).
Conclusions:
We confirmed increased prevalence of abnormal LVEDD, LVMI, diastolic function, LAVI, and PASP in SCD. In addition, we identified abnormal LV MPI (78%), TAPSE (29%). These parameters may be useful and readily accessible echocardiographic prognostic tools in this population.
More Related Videos
Related Concept Videos
Wave Parameters
Distributions to Estimate Population Parameter
Dosage Regimens: Partial Pharmacokinetic Parameters
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
Identifying Statistically Significant Differences: The F-Test
Factors Influencing Drug Absorption: Anatomical Parameters

